Quest Diagnostics posts blowout Q3 on strong COVID-19 demand, ups guidance

• Quest Diagnostics (NYSE:DGX) Q3 results:
• Revenues: $2,786M (+42.5%).
• Net income: $568M (+164.7%); non-GAAP net income: $591M (+144.9%); EPS: $4.14 (+164.6%); non-GAAP EPS: $4.31 (+144.9%).
• Cash flow ops: $862M (+189.0%).
• 2020 guidance: Revenues: $8.8B-9.1B from $8.4B-8.8B; EPS: $8.22-9.22 from $7.42-8.92; non-GAAP EPS: $9.00-10.00 from $7.50-9.00; cash flow ops: at least $1.75B from at least $1.45B.
• https://seekingalpha.com/news/3624704-quest-diagnostics-posts-blowout-q3-on-strong-covidminus-19-demand-boosts-guidance